APOE and Alzheimer disease: Assessment of the blood redox status of patients with AD (males and females were included) in accordance with their ApoE genotypes showed that the epsilon4 allele carriers (patients with AD as well as control volunteers) are characterized by lower uricemia and lower catechol-O-methyltransferase activity in erythrocytes [57].